This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Using your skills to make money is a smart move. Explore various strategies to effectively leverage your talents and boost your earnings.
20,136 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Nuclear energy has moved from niche to core in many energy plans. This guide breaks down the best nuclear energy stoc...
Futures markets show how traders see the near-term path for oil, stocks, and currencies. This explainer breaks down t...
In volatile markets, investors seek safety. This guide compares gold, silver, bitcoin, and dividend stocks as safe ha...
Meta Platforms is signaling a bold pivot toward AI-focused cloud capacity. This article breaks down what neocloud wou...
Aflac has a remarkable 43-year streak of raising its dividend, a hallmark many income investors look for. But that st...
A modest Tuesday gain for SPGI helped the stock beat the broad market's small rise. This piece explains what a global...
A major fund trimmed its LKQ position by 777,000 shares, raising questions about what this means for the stock and th...
As regulators settle the status of digital assets and major networks scale, XRP and Solana remain top bets for a long...
This guide helps you understand the drivers behind the group (rily) 2025 earnings for BRC Group under RILY. It breaks...
A sudden regulatory shift around tokenized stocks has sparked a wave of excitement and confusion. This Morning Minute...
A recent SEC filing shows Pale Fire Capital expanding its Ziff Davis position. This move offers clues about hedge fun...